203 related articles for article (PubMed ID: 36678681)
1. Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells.
Komedchikova EN; Kolesnikova OA; Tereshina ED; Kotelnikova PA; Sogomonyan AS; Stepanov AV; Deyev SM; Nikitin MP; Shipunova VO
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678681
[TBL] [Abstract][Full Text] [Related]
2. Targeted Two-Step Delivery of Oncotheranostic Nano-PLGA for HER2-Positive Tumor Imaging and Therapy In Vivo: Improved Effectiveness Compared to One-Step Strategy.
Shipunova VO; Komedchikova EN; Kotelnikova PA; Nikitin MP; Deyev SM
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986694
[TBL] [Abstract][Full Text] [Related]
3. Barnase*Barstar-guided two-step targeting approach for drug delivery to tumor cells in vivo.
Shramova EI; Shilova MV; Ryabova AV; Dzhalilova DS; Zolotova NA; Telegin GB; Deyev SM; Proshkina GM
J Control Release; 2021 Dec; 340():200-208. PubMed ID: 34740723
[TBL] [Abstract][Full Text] [Related]
4. Versatile Platform for Nanoparticle Surface Bioengineering Based on SiO
Shipunova VO; Zelepukin IV; Stremovskiy OA; Nikitin MP; Care A; Sunna A; Zvyagin AV; Deyev SM
ACS Appl Mater Interfaces; 2018 May; 10(20):17437-17447. PubMed ID: 29701945
[TBL] [Abstract][Full Text] [Related]
5. Dual Regioselective Targeting the Same Receptor in Nanoparticle-Mediated Combination Immuno/Chemotherapy for Enhanced Image-Guided Cancer Treatment.
Shipunova VO; Komedchikova EN; Kotelnikova PA; Zelepukin IV; Schulga AA; Proshkina GM; Shramova EI; Kutscher HL; Telegin GB; Kabashin AV; Prasad PN; Deyev SM
ACS Nano; 2020 Oct; 14(10):12781-12795. PubMed ID: 32935975
[TBL] [Abstract][Full Text] [Related]
6. Targeted Delivery of HSP70 to Tumor Cells via Supramolecular Complex Based on HER2-Specific DARPin9_29 and the Barnase:Barstar Pair.
Alekseeva LG; Ovsyanikova OV; Schulga AA; Grechikhina MV; Shustova OA; Kovalenko EI; Svirshchevskaya EV; Deyev SM; Sapozhnikov AM
Cells; 2024 Feb; 13(4):. PubMed ID: 38391930
[TBL] [Abstract][Full Text] [Related]
7. Barnase-Barstar Pair: Contemporary Application in Cancer Research and Nanotechnology.
Shilova O; Kotelnikova P; Proshkina G; Shramova E; Deyev S
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833876
[TBL] [Abstract][Full Text] [Related]
8. Bioengineering bacterial encapsulin nanocompartments as targeted drug delivery system.
Van de Steen A; Khalife R; Colant N; Mustafa Khan H; Deveikis M; Charalambous S; Robinson CM; Dabas R; Esteban Serna S; Catana DA; Pildish K; Kalinovskiy V; Gustafsson K; Frank S
Synth Syst Biotechnol; 2021 Sep; 6(3):231-241. PubMed ID: 34541345
[TBL] [Abstract][Full Text] [Related]
9. PLGA Nanoparticles Decorated with Anti-HER2 Affibody for Targeted Delivery and Photoinduced Cell Death.
Shipunova VO; Sogomonyan AS; Zelepukin IV; Nikitin MP; Deyev SM
Molecules; 2021 Jun; 26(13):. PubMed ID: 34203547
[TBL] [Abstract][Full Text] [Related]
10. A Novel Approach to Anticancer Therapy: Molecular Modules Based on the Barnase:Barstar Pair for Targeted Delivery of HSP70 to Tumor Cells.
Sapozhnikov AM; Klinkova AV; Shustova OA; Grechikhina MV; Kilyachus MS; Stremovskiy OA; Kovalenko EI; Deyev SM
Acta Naturae; 2018; 10(3):85-91. PubMed ID: 30397532
[TBL] [Abstract][Full Text] [Related]
11. Protein-protein recognition: crystal structural analysis of a barnase-barstar complex at 2.0-A resolution.
Buckle AM; Schreiber G; Fersht AR
Biochemistry; 1994 Aug; 33(30):8878-89. PubMed ID: 8043575
[TBL] [Abstract][Full Text] [Related]
12. Tumor targeting using anti-her2 immunoliposomes.
Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
[TBL] [Abstract][Full Text] [Related]
13. Heterodimeric barnase-barstar vaccine molecules: influence of one versus two targeting units specific for antigen presenting cells.
Spång HC; Braathen R; Bogen B
PLoS One; 2012; 7(9):e45393. PubMed ID: 23028981
[TBL] [Abstract][Full Text] [Related]
14. [Targeted Delivery of Quantum Dots to HER2-Expressing Tumor Using Recombinant Antibodies].
Balalaeva IV; Zdobnova TA; Sokolova EA; Deyev SM
Bioorg Khim; 2015; 41(5):599-605. PubMed ID: 26762098
[TBL] [Abstract][Full Text] [Related]
15. Protein-protein interaction: a genetic selection for compensating mutations at the barnase-barstar interface.
Jucovic M; Hartley RW
Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2343-7. PubMed ID: 8637875
[TBL] [Abstract][Full Text] [Related]
16. A novel cell ablation strategy blocks tobacco anther dehiscence.
Beals TP; Goldberg RB
Plant Cell; 1997 Sep; 9(9):1527-45. PubMed ID: 9338959
[TBL] [Abstract][Full Text] [Related]
17. Design of multivalent complexes using the barnase*barstar module.
Deyev SM; Waibel R; Lebedenko EN; Schubiger AP; Plückthun A
Nat Biotechnol; 2003 Dec; 21(12):1486-92. PubMed ID: 14634668
[TBL] [Abstract][Full Text] [Related]
18. A new vector for controllable expression of an anti-HER2/neu mini-antibody-barnase fusion protein in HEK 293T cells.
Glinka EM; Edelweiss EF; Sapozhnikov AM; Deyev SM
Gene; 2006 Jan; 366(1):97-103. PubMed ID: 16300908
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional HER2-antibody conjugated polymeric nanocarrier-based drug delivery system for multi-drug-resistant breast cancer therapy.
Vivek R; Thangam R; NipunBabu V; Rejeeth C; Sivasubramanian S; Gunasekaran P; Muthuchelian K; Kannan S
ACS Appl Mater Interfaces; 2014 May; 6(9):6469-80. PubMed ID: 24780315
[TBL] [Abstract][Full Text] [Related]
20. The role of Glu73 of barnase in catalysis and the binding of barstar.
Schreiber G; Frisch C; Fersht AR
J Mol Biol; 1997 Jul; 270(1):111-22. PubMed ID: 9231905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
